Cholera clinical trials
The registry lists 74 studies for Cholera across more than 10 countries. 11 are recruiting or about to start. Per ClinicalTrials.gov, last updated 2026-08-31.
Status
- Completed
- 52
- Recruiting
- 9
- Status unknown
- 6
- Terminated
- 4
- Not yet recruiting
- 2
- Withdrawn
- 1
Phase
- Phase 2
- 19
- Phase 3
- 17
- Phase 1
- 9
- Phase 4
- 8
Where
- Bangladesh
- 28
- India
- 12
- United States
- 10
- Zambia
- 3
- Congo, The Democratic Republic of the
- 3
- Korea, Republic of
- 2
Who runs them
International Centre for Diarrhoeal Disease Research, Bangladesh (16) · International Vaccine Institute (16) · Johns Hopkins Bloomberg School of Public Health (8) · Bavarian Nordic (5) · PATH (4) · National Institute of Allergy and Infectious Diseases (NIAID) (2) · Epicentre (2) · Massachusetts General Hospital (2)
Studies
Recruiting first, then most recently updated. Showing 50 of 74 — search for more.
- Ondansetron to Prevent Oral Rehydration Failure in Children With CholeraNot yet recruitingNCT07795060Phase 21 country
- Phase 1b Ascending Dose Study of PanChol in Healthy VolunteersRecruitingNCT07107516Phase 11 country
- Cholera Control by Case-area Targeted Interventions (CATIs)RecruitingNCT07685574Not applicable1 country
- Testing a Scalable Model of the Cholera Hospital-Based Intervention for 7 Days (CHoBI7)RecruitingNCT06498817Not applicable1 country
- Vaccine- and Infection-derived Correlates of Protection for CholeraRecruitingNCT06455852Not applicable1 country
- Extended Dosing Intervals Trial for Oral Cholera Vaccine, KenyaRecruitingNCT07487077Phase 41 country
- Preventative Intervention for Cholera for 7 DaysRecruitingNCT05166850Not applicable1 country
- Cholera-Hospital-Based-Intervention-for-7-Days (CHoBI7) Water, Sanitation, and Hygiene (WASH) Case Area Targeted Intervention (CATI)RecruitingNCT06003816Not applicable1 country
- Impact Study of Cholera Vaccination in Endemic Areas - Clinical SurveillanceRecruitingNCT048531861 country
- Co-administration Study of OCV, TCV and MRNot yet recruitingNCT05771779Phase 3
- First in Human Phase 1 Ascending Dose Study of PanChol in Healthy VolunteersRecruitingNCT05657782Phase 11 country
- Single Dose Azithromycin to Prevent Cholera in ChildrenCompletedNCT04326478Phase 21 country
- Assessment of a Novel Fixed-dose Combination (FDC) Drug VR-AD-1005 for the Treatment of Acute Watery Diarrhea in CholeraCompletedNCT06193408Phase 21 country
- Next Generation ORS: Comparing ORS With Calcium vs Standard ORS in Reducing Severity of Acute Watery DiarrheaCompletedNCT05814042Phase 2/31 country
- Immunologic Responses to a Live Attenuated Oral Cholera VaccineCompletedNCT03251495Phase 21 country
- Simulation Based Training In Medical StudentsCompletedNCT06929312Not applicable1 country
- Dose Escalation Study to Evaluate the Safety and Immunogenicity of the Cholera Conjugate Vaccine in Healthy AdultsCompletedNCT05559983Phase 11 country
- Impact Study of Cholera Vaccination in Endemic Areas - SeroprevalenceCompletedNCT058297721 country
- Water, Sanitation, and Hygiene Mobile Health Messages as an Innovative Tool to Facilitate Behavior ChangeCompletedNCT04816552Not applicable1 country
- Follow-up of Pregnant Women After a Mass Vaccination of Oral Cholera Vaccine (ShancholTM) in Nsanje MalawiTerminatedNCT02499172Not applicable1 country
- A Study of Live Oral Cholera Vaccine, PXVX200 in Healthy Older AdultsCompletedNCT02100631Phase 31 country
- Safety and Efficacy Challenge Study of Live Oral Cholera Vaccine Candidate,PXVX0200, to Prevent CholeraCompletedNCT01895855Phase 31 country
- A Phase 3 Lot to Lot Consistency Study of Live Oral Cholera Vaccine, PXVX0200 in Healthy AdultsCompletedNCT02094586Phase 32 countries
- VAXCHORA Pediatric Study to Assess Safety and ImmunogenicityCompletedNCT03220737Phase 41 country
- Safety and Immunogenicity of the Live Oral Cholera Vaccine Candidate PXVX0200CompletedNCT01585181Phase 11 country
- Immune Non-Inferiority, Safety and Lot-to-Lot Consistency of Oral Cholera Vaccine-Simplified Compared to Shanchol™CompletedNCT04760236Phase 31 country
- To Evaluate Safety of Oral Cholera Vaccine Hillchol® (BBV131)Status unknownNCT05732766Phase 31 country
- Blood Donor CVD 9000TerminatedNCT03724357Phase 41 country
- Extended Dose Intervals With Oral Cholera Vaccine in CameroonCompletedNCT03719066Phase 21 country
- Impact Evaluation of Urban Water Supply Improvements on Cholera and Other Diarrhoeal Diseases in Uvira, Democratic Republic of CongoCompletedNCT02928341Not applicable1 country
- A Phase III Randomized, Modified Double-blind, Multi-centric, Comparative Study, to Evaluate the Non-inferiority of Immunogenicity and Safety of Hillchol® (BBV131)to Shanchol™ Along With Lot-to-lot Consistency of Hillchol®(BBV131).Status unknownNCT05507229Phase 31 country
- Immunological Characteristics of a Population at Risk of Cholera After Oral Cholera Vaccine (CHOVAXIM)CompletedNCT04423159Not applicable1 country
- Immunogenicity of Co-administered Oral Polio Vaccine and Oral Cholera VaccineStatus unknownNCT03581734Phase 31 country
- Single Dose Ciprofloxacin in the Treatment of Childhood Cholera:Randomized Controlled Clinical TrialCompletedNCT00142272Phase 31 country
- Cholera-Hospital-Based-Intervention-for-7-daysCompletedNCT04008134Not applicable
- Effect of Extended Dose Intervals on the Immune Response to Oral Cholera VaccineCompletedNCT03373669Phase 41 country
- Cholera Anti-Secretory Treatment TrialCompletedNCT04150250Phase 21 country
- Cholera Vaccine Investment Strategy in BangladeshCompletedNCT027278551 country
- Immunity to Human Cholera in BangladeshCompletedNCT004019341 country
- Safety and Immunogenicity of Locally Manufactured New (HL-OCV) Oral Cholera VaccineCompletedNCT02823899Phase 1/21 country
- A Study of Two Doses of Oral Cholera Vaccine (Shanchol™) in Subjects Aged 1 Year and Older in Dominican RepublicCompletedNCT02434822Phase 31 country
- A Study of Two Doses of Oral Cholera Vaccine (Shanchol™) in Subjects Aged 1 Year and Older in the PhilippinesCompletedNCT01949675Phase 41 country
- Single Dose Oral Cholera Vaccine Study in Dhaka, BangladeshCompletedNCT02027207Phase 31 country
- Safety of An Oral O1 / O139 Cholera Vaccine (Enteric Capsules)CompletedNCT03237663Phase 1
- Safety and Immunogenicity of Locally Manufactured Oral Cholera VaccineCompletedNCT02742558Phase 21 country
- Effect of Raw Milk on the Immune Response Upon Cholera VaccinationCompletedNCT02238548Not applicable1 country
- Introduction of Cholera Vaccine in BangladeshCompletedNCT01339845Not applicable1 country
- Safety and Immunogenicity of a New Formulation of Euvichol®Status unknownNCT02502331Phase 3
- Oral Cholera Vaccine Delivery in Rural BangladeshCompletedNCT01811771Not applicable1 country
- PK Study of iOWH032 in Adult Male/Female Healthy Volunteers & Adult Males With CholeraCompletedNCT01823939Phase 11 country